Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01723020
Title A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

Advanced Solid Tumor

multiple myeloma

Therapies

KRT-232

Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.